News

Sarepta’s big gene therapy expansion; Inside Iambic’s AI cycle; Vertex, Lilly unveil new diabetes data; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

No Picture
News

OrsoBio to Present Phase 1 and Preclinical Data for Liver-Targeted Mitochondrial Protonophore TLC-6740 at the American Diabetes Association’s 84th Scientific Sessions

MENLO PARK, Calif.–(BUSINESS WIRE)– #ada2024–OrsoBio shares data on liver-targeted mitochondrial protonophore TLC-6740 at the 84th Scientific Sessions of the American Diabetes Association. Click here to view original post Click Here to Publish/Feature Your Company or […]

News

Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation

The financing will further scale BillionToOne’s prenatal screening and oncology diagnostics businesses MENLO PARK, Calif., June 21, 2024 /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company, announced today that it has raised $130 million in […]

News

The Endpoints Slack interview: Saji Wickramasekara on where AI misses the mark — and what’s next for Benchling

As a 22-year-old undergraduate, Saji Wickramasekara followed a well-worn tech world script that remains nearly unheard of in biotech — he dropped out of MIT and co-founded a startup. Twelve years later, Wickramasekara is still […]